83341-28-0

Basic information

• Product Name: 5-Fluoro-4-Methyl-2-nitrophenol
• Synonyms: 5-Fluoro-4-Methyl-2-nitrophenol
• CAS NO: 83341-28-0
• Molecular Formula: C₇H₆FNO₃
• Molecular Weight: 171.1258432
• Mol File: 83341-28-0.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-Fluoro-4-Methyl-2-nitrophenol(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Fluoro-4-Methyl-2-nitrophenol(83341-28-0)
• EPA Substance Registry System: 5-Fluoro-4-Methyl-2-nitrophenol(83341-28-0)

Safety Data

• Hazardous Substances Data: 83341-28-0(Hazardous Substances Data)

Usage

General Description

5-Fluoro-4-Methyl-2-nitrophenol, also known as 4-methyl-5-nitro-2-fluorophenol, is a chemical compound with the molecular formula C7H6FNO3. It is a pale yellow crystalline solid and is used as an intermediate in the synthesis of various pharmaceutical and agricultural products. 5-Fluoro-4-Methyl-2-nitrophenol is typically produced by the nitration of 4-methyl-5-fluorophenol and has potential uses as an antimicrobial and antifungal agent. It is important to handle this compound with care and follow proper safety protocols due to its potential hazards.

Upstream product

• 18349-11-6 1-chloro-5-fluoro-4-methyl-2-nitrobenzene 
• 452-78-8 3-fluoro-4-methyl phenol 

Relevant articles and documents

Novel(1,2,4)triazolo(1,5-a)pyridylphosphine oxide and use thereof

The present invention relates to novel(1,2,4)triazolo(1,5-a)pyridinyl phosphorus oxides and uses thereof. Wherein the compound is a compound represented by a formula I, or a pharmaceutically acceptable salt thereof, or a hydrate thereof, or a solvate thereof, or a metabolite thereof, or a stereoisomer thereof, or a tautomer thereof, or a prodrug thereof, and R1 to R5 are as defined in the specification. The compound disclosed by the invention can be used for preparing a medicine for treating and/or preventing cancers.

Tyrosine Kinase Inhibitor And Uses Thereof

Disclosed is a compound of Formula (I) or a pharmaceutically acceptable salt, ester, or solvate thereof, or their stereoisomers, which can be used as tyrosine kinase inhibitor. Also disclosed is a method for preparing the compound, a pharmaceutical composition and a kit comprising the compound, and uses of the compound. The compound can be used as tyrosine kinase inhibitor, or can be used to reduce or inhibit activity of EGFR or mutant thereof, such as EGFR mutant comprising T790M mutation, in a cell, or to treat and/or prevent a disease associated with overactivity of EGFR, such as cancer.

COMPOUNDS WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE

Compounds of formula (I) or a salt thereof are provided: wherein R4, R5, R6, Q, A, Y and R are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments for treating psychotic disorders, cognitive impairments and Alzheimer's Disease are disclosed. The invention further discloses pharmaceutical compositions comprising the compounds.